Skip to main content
. 2022 Aug 1;78(3):279–292. doi: 10.1016/j.therap.2022.07.009

Table 3.

Rechallenge data available in Vigibase, the WHO global pharmacovigilance database.

Rechallenge Tozinameran Elasomeran ChAdOx1 nCoV-19 Ad26.CoV2.S Total
Positive 14 4 1 1 20
Negative 20 1 8 29
Rate (95% CI) of positive rechallenge 41 (25–59) 80 (28–99) 11 (0–48) 41 (27–56)

CI: confidence interval; WHO: World Health Organization.